TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Intake Breathing has received a $62 million investment from Camino Partners, marking its first significant outside capital infusion. The company says it plans to use the funding to expand into physical retail and specialty channels and make key hires; details on the investment terms were not reported.
Intake Breathing, which sells a reusable magnetic nasal dilator, has received a $62 million investment from Camino Partners, the firm founded by Kind Snacks creator Daniel Lubetzky. The funding gives the family-run company its first significant outside capital and will support plans to expand into physical retail and specialty channels.
Intake was founded by Jim Castillo, an inventor and medical device engineer, and is led by his son-in-law, co-founder and CEO Alex Hauck. Its product uses a reusable magnetic band and adhesive tabs to mechanically open the nasal valve, the narrowest part of the nasal airway. The design differs from conventional adhesive nasal strips, according to the company’s product description.
The company said it will put the investment toward retail and specialty-channel expansion and key hires to support growth. Intake has built its business primarily through direct-to-consumer sales; the move into physical outlets would broaden how customers can find the product. The report did not specify which retailers or specialty channels are in discussion, or when new listings are expected.
Hauck described the deal as providing both capital and an experienced consumer-brand partner. Camino is led by Lubetzky, and its portfolio includes Barry’s and Athletic Brewing, among other health-oriented businesses. The source report did not disclose the investment structure, Camino’s ownership stake, or whether the full $62 million has already been transferred.
A Retail Push for Nasal Devices
The investment gives Intake resources to pursue a larger customer base beyond online sales, at a time when the company and its backer see opportunity in consumer interest in sleep, recovery and performance. Retail distribution could make the product easier to discover and buy, while hiring may give Intake more capacity to manage sales and operations as it grows. Those are stated plans, not evidence yet of expanded availability or commercial results.
Camino’s backing also signals an effort to build nasal breathing products into a broader wellness category, rather than keeping them associated mainly with drugstore remedies. That market ambition is the investors’ thesis; the source does not provide independent sales data or research showing how large demand for magnetic nasal devices is. Intake’s ability to convert its direct-to-consumer following into repeat retail demand remains to be seen.
The product’s positioning touches on health-related interests, but the funding announcement does not establish that the device treats a medical condition or produces specific health outcomes. The report describes how the device is designed to affect airflow; it does not present clinical findings or independent evidence of benefits. That distinction matters as the company expands marketing and distribution.
Products Worth Considering
Withings Body Smart Wi-Fi and Bluetooth Body Composition Scale
BowFlex Results Series SelectTech Adjustable Dumbbells (Pair)
Oura Ring 4 Smart Ring – Silver – Size 8
As an affiliate, we earn on qualifying purchases.
From Direct Sales to Wider Distribution
Intake began as a solution Castillo developed in his garage, Hauck said. The company has since built a primarily direct-to-consumer business around its magnetic nasal dilator. The $62 million investment marks a step from that base toward wider retail and specialty distribution, according to the company’s plans described in the report.
The report places the deal within growing commercial interest in breathing optimization among fitness and wellness consumers. It says Intake has attracted professional athletes, including Los Angeles Dodgers pitcher Justin Wrobleski and Belgian soccer player Amadou Onana. Their association with the brand does not, on its own, establish product effectiveness or indicate that they endorse particular medical claims.
Camino’s stated comparison is to its experience building Kind, which it says helped make healthier snacks more familiar to consumers. The firm sees a similar opening for nasal breathing products. That is an investor’s view of the market, not a demonstrated forecast. The investment also adds Intake to a portfolio that includes fitness and wellness businesses such as Barry’s and Athletic Brewing.
“We’re not just gaining capital, we’re gaining a partner who knows exactly what it takes to help get us there.”
— Alex Hauck, Intake Breathing co-founder and CEO
Investment Terms and Rollout Details
The source report does not provide the investment terms, Camino’s ownership stake, or information about governance rights. It also does not say whether the $62 million is a single completed transfer or a commitment with conditions. Those details would clarify the structure of Camino’s backing.
Intake has not named retailers, specialty partners, locations, or a launch timetable for its planned expansion. The report also gives no financial results, unit sales, customer-retention figures, or breakdown of how much of the funding will go to hiring versus distribution. It remains unclear how quickly the company expects its retail presence to grow.
The available source material does not include clinical evidence about the device’s effects or independent assessment of its performance. The company’s product description and the investor’s market outlook should not be read as proof of health outcomes or of future consumer demand.
Retail Plans and Hiring Ahead
Intake’s next stated steps are to pursue physical retail and specialty channels and make key hires. The company has not announced specific partners or dates, so the practical test will be whether those plans lead to wider availability and sustained sales beyond its direct-to-consumer base.
Further updates may clarify the investment terms, the rollout schedule, and how the company intends to support distribution. Until those details are released, the confirmed development is the $62 million backing and Intake’s stated growth plans—not a completed retail expansion or a verified change in consumer demand.
Key Questions
Who invested $62 million in Intake Breathing?
Camino Partners, the investment firm founded by Daniel Lubetzky, made the investment, according to the source report.
What does Intake Breathing sell?
Intake sells a nasal dilator that uses a reusable magnetic band and adhesive tabs to mechanically open the nasal valve. The source describes the device’s design but does not provide clinical evidence of health benefits.
How does Intake plan to use the funding?
The company says it plans to expand into physical retail and specialty channels and make key hires. It has not named retail partners or given a rollout timetable.
Were the investment terms disclosed?
No. The report gives the investment amount but does not specify Camino’s ownership stake, the deal structure, or whether the funding was transferred at once.
Does the investment prove the nasal device improves health?
No. The funding announcement and product description do not establish medical effectiveness. The source report does not include independent clinical findings or evidence of specific health outcomes.
Source: rss
